ATE240097T1 - Pharmaceutische zusammensetzung enthaltend (+)- ephedrin und einen h1 rezeptor antagonisten - Google Patents

Pharmaceutische zusammensetzung enthaltend (+)- ephedrin und einen h1 rezeptor antagonisten

Info

Publication number
ATE240097T1
ATE240097T1 AT98956561T AT98956561T ATE240097T1 AT E240097 T1 ATE240097 T1 AT E240097T1 AT 98956561 T AT98956561 T AT 98956561T AT 98956561 T AT98956561 T AT 98956561T AT E240097 T1 ATE240097 T1 AT E240097T1
Authority
AT
Austria
Prior art keywords
ephedrine
pharmaceutical composition
composition containing
receptor antagonist
substantially free
Prior art date
Application number
AT98956561T
Other languages
English (en)
Inventor
Anthony R Booth
William T Sherman
Peter Raven
James L Caffrey
Thomas Yorio
Michael Forster
Patricia Gwirtz
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE240097T1 publication Critical patent/ATE240097T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98956561T 1997-11-14 1998-11-04 Pharmaceutische zusammensetzung enthaltend (+)- ephedrin und einen h1 rezeptor antagonisten ATE240097T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6557297P 1997-11-14 1997-11-14
PCT/US1998/023479 WO1999025328A1 (en) 1997-11-14 1998-11-04 (+)-ephedrine as a sympathomimetic drug

Publications (1)

Publication Number Publication Date
ATE240097T1 true ATE240097T1 (de) 2003-05-15

Family

ID=22063647

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98956561T ATE240097T1 (de) 1997-11-14 1998-11-04 Pharmaceutische zusammensetzung enthaltend (+)- ephedrin und einen h1 rezeptor antagonisten

Country Status (8)

Country Link
EP (1) EP1030659B1 (de)
AT (1) ATE240097T1 (de)
AU (1) AU1305999A (de)
DE (1) DE69814669T2 (de)
DK (1) DK1030659T3 (de)
ES (1) ES2199474T3 (de)
PT (1) PT1030659E (de)
WO (1) WO1999025328A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1314199B1 (it) * 1999-10-20 2002-12-06 Ambros Pharma S R L Composizioni contenenti sostanze ad attivita' adrenergica ed estrattivegetali per il trattamento del sovrappeso e obesita'
DE10148233A1 (de) * 2001-09-28 2003-04-10 Boehringer Ingelheim Pharma Verbindungen zur Reduzierung übermäßiger Nahrungsaufnahme

Also Published As

Publication number Publication date
AU1305999A (en) 1999-06-07
PT1030659E (pt) 2003-09-30
DE69814669D1 (de) 2003-06-18
WO1999025328A1 (en) 1999-05-27
EP1030659A1 (de) 2000-08-30
DK1030659T3 (da) 2003-09-15
DE69814669T2 (de) 2003-11-27
EP1030659B1 (de) 2003-05-14
ES2199474T3 (es) 2004-02-16

Similar Documents

Publication Publication Date Title
GEP20022784B (en) Celecoxib Composition
IS4146A (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
GR1002097B (en) A process for providing a composition an analgesic in combination with a h1 or h2 receptor blocker proto n pump ihibitor or combination thereof
EP0783299A4 (de) Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe
NO993520D0 (no) Doseringsformer og fremgangsmåte for å bedre erektil dysfunksjon
MY118371A (en) Tetrahydrolipstatin containing compositions
GEP20002013B (en) Therapeutical Means
CA2260943A1 (en) Formulation of 5-ht agonists
NZ319531A (en) An analgesic synergistic composition containing a sub-analgesic dose of a mu opioid agonist and a kappa-2 opiod agonist
GEP20033131B (en) Azabicycloalkanes as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Activity
ATE311867T1 (de) Analgetische zusammensetzung enthaltend antiepileptische arzneistoffe und deren verwendungen
IL76932A (en) Synergistic pharmaceutical analgesic compositions containing dihydrocodeine and ibuprofen
MXPA02007690A (es) Composiciones de liberacion controlada que contienen agonista y antiagonista de opioide.
BR0012080A (pt) Métodos e composições para administração intranasal de apomorfina
PL320883A1 (en) Transdermal system for simultaneous transdermal administration of several active substances
FR2735369B1 (fr) Compositions pharmaceutiques a base de sel de sodium du diclofenac et de thiocolchicoside
EP0663835A1 (de) Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft.
ES2189252T3 (es) Composiciones analgesicas que comprenden un antagonista de la colecistoquinina y un opioide.
PL348202A1 (en) Pharmaceutically active composition and dispensing device
AP2001002084A0 (en) Orally administered controlled delivery system for once daily adminstration of ciprofloxacin
GEP20043313B (en) Use of Pharmaceutical Composition for Treatment of Endometriosis or Infertility, or Improving Fertility
MY126321A (en) Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer.
DE69814669T2 (de) Pharmaceutische Zusammensetzung enthaltend (+)-EPHEDRIN und einen H1 Rezeptor Antagonisten
HK1026843A1 (en) Somatostatin and somatostatin agonists for treating insulin insensitivity and syndrome x.
AU3278800A (en) Pharmaceutical composition containing desoxypeganine for the treatment of drug dependence

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1030659

Country of ref document: EP

REN Ceased due to non-payment of the annual fee